Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Microbiol Spectr ; 12(3): e0501622, 2024 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-38289115

RESUMEN

Infectious hematopoietic necrosis virus (IHNV) causes infectious hematopoietic necrosis and severe economic losses to salmon and trout aquaculture worldwide. Currently, the only commercial vaccine against IHNV is a DNA vaccine with some biosafety concerns. Hence, more effective vaccines and antiviral drugs are needed to prevent IHNV infection. In this study, 1,483 compounds were screened from a traditional Chinese medicine monomer library, and bufalin showed potential antiviral activity against IHNV. The 50% cytotoxic concentration of bufalin was >20 µM, and the 50% inhibitory concentration was 0.1223 µΜ against IHNV. Bufalin showed the inhibition of diverse IHNV strains in vitro, which confirmed that it had an inhibitory effect against all IHNV strains, rather than random activity against a single strain. The bufalin-mediated block of IHNV infection occurred at the viral attachment and RNA replication stages, but not internalization. Bufalin also inhibited IHNV infection in vivo and significantly increased the survival of rainbow trout compared with the mock drug-treated group, and this was confirmed by in vivo viral load monitoring. Our data showed that the anti-IHNV activity of bufalin was proportional to extracellular Na+ concentration and inversely proportional to extracellular K+ concentration, and bufalin may inhibit IHNV infection by targeting Na+/K+-ATPase. The in vitro and in vivo studies showed that bufalin significantly inhibited IHNV infection and may be a promising candidate drug against the disease in rainbow trout. IMPORTANCE: Infectious hematopoietic necrosis virus (IHNV) is the pathogen of infectious hematopoietic necrosis (IHN) which outbreak often causes huge economic losses and hampers the healthy development of salmon and trout farming. Currently, there is only one approved DNA vaccine for IHN worldwide, but it faces some biosafety problems. Hence, more effective vaccines and antiviral drugs are needed to prevent IHNV infection. In this study, we report that bufalin, a traditional Chinese medicine, shows potential antiviral activity against IHNV both in vitro and in vivo. The bufalin-mediated block of IHNV infection occurred at the viral attachment and RNA replication stages, but not internalization, and bufalin inhibited IHNV infection by targeting Na+/K+-ATPase. The in vitro and in vivo studies showed that bufalin significantly inhibited IHNV infection and may be a promising candidate drug against the disease in rainbow trout.


Asunto(s)
Bufanólidos , Enfermedades de los Peces , Virus de la Necrosis Hematopoyética Infecciosa , Oncorhynchus mykiss , Vacunas de ADN , Animales , Virus de la Necrosis Hematopoyética Infecciosa/genética , Medicina Tradicional China , Antivirales/farmacología , Antivirales/uso terapéutico , Adenosina Trifosfatasas , Necrosis , Enfermedades de los Peces/tratamiento farmacológico , Enfermedades de los Peces/prevención & control
2.
Inorg Chem ; 43(20): 6331-3, 2004 Oct 04.
Artículo en Inglés | MEDLINE | ID: mdl-15446880

RESUMEN

Ab initio theoretical evidence of hexacoordinate planar main group atoms centered in hexagonal hydrocopper complexes Cu(6)H(6)X (X = Si, P, As) is presented at the density functional theory level in this work. The results obtained extend the bonding capacity of silicon, phosphorus, and arsenic to planar hexacoordination in hydrocopper complexes which are important in fundamental research and may shed new insight into catalyst chemistry.


Asunto(s)
Arsénico/química , Cobre/química , Compuestos Organometálicos/química , Fósforo/química , Silicio/química , Simulación por Computador , Modelos Químicos , Modelos Moleculares
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA